Announcements Trials
Browse Landscape

Status

Active not recruiting 1

Sponsor Class

NIH 2OTHER 1

Study Type

Observational 1

Sponsor

Conditions

Breast Neoplasms 26Prostatic Neoplasms 24Brain Neoplasms 21Neoplasms 13Glioma 10Head and Neck Neoplasms 8Pancreatic Neoplasms 7Glioblastoma 6Lung Neoplasms 5Colonic Neoplasms 5Carcinoma, Hepatocellular 5Astrocytoma 5Uterine Cervical Neoplasms 4Squamous Cell Carcinoma of Head and Neck 4Rectal Neoplasms 4Lymphoma 4Central Nervous System Neoplasms 4Urinary Bladder Neoplasms 3Triple Negative Breast Neoplasms 3Spinal Cord Neoplasms 3Sarcoma 3Liver Neoplasms 3Disease 3Retinoblastoma 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Pathologic Complete Response 2Oligodendroglioma 2Neurofibromatosis 1 2Meningioma 2Lymphoma, Non-Hodgkin 2

Interventions

toripalimab 1durvalumab 1advexin 1Surveys and Questionnaires 1Sampling Studies 1Nivolumab 1Mitomycin 1Mastectomy, Subcutaneous 1Magnetic Resonance Imaging 1Gemcitabine 1Erlotinib Hydrochloride 1Docetaxel 1Cystoscopy 1Cholecalciferol 1Blood Specimen Collection 1Biopsy 1Aminolevulinic Acid 11-phenyl-3,3-dimethyltriazene 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Carcinoma in Situ × Magnetic Resonance Imaging × Clear all
NCT06744140 2024-12-20

Role of MRI Breast in Detection of Ductal Carcinoma in Situ

Superior University

Active not recruiting
35 enrolled

Carcinoma in Situ

Data powered by HemOnc (CC BY 4.0) Colophon âš¡